Miranti has been a speaker, consultant, and/or advisory board member for Almirall, Arcutis Biotherapeutics, Dermavant, EPI Health, Galderma, Incyte, Journey, Ortho Dermatologics, Emblation Ltd, and Verrica, and an editorial advisory board member for Dermatology Times
For individuals with a Body Mass Index (BMI) above the healthy range, embarking on a weight loss journey becomes particularly beneficial, especially when coupled with other health risk factors like high blood pressure, cholesterol, smoking, diabetes, sedentary lifestyle, and a personal/family history of heart disease
Switching from injectable to oral semaglutide, or vice versa, sometimes changes symptom severity due to absorption and delivery differences
Wound Healing and Skin Research This is the most studied application, and the data is extensive